PAS
BCAB icon

Point72 Asia (Singapore)’s BioAtla BCAB Stock Holding History

Point72 Asia (Singapore)’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-477
Closed -$14.1K – 881
2024
Q4 		$14.1K Sell
477
-261
-35% -$21.9K ﹤0.01% 707
2024
Q3 		$64.9K Sell
738
-706
-49% -$59.2K 0.01% 642
2024
Q2 		$98.9K Buy
+1,444
New +$172K 0.02% 491

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return

Point72 Asia (Singapore)'s BCAB Position: Q1 2025 in Review

Point72 Asia (Singapore) sold out of BioAtla (BCAB) in Q1 2025, closing a stake of 477 shares — an estimated $14.1K sold.

Point72 Asia (Singapore) first reported a position in BCAB in Q2 2024 and held it in 3 quarters. The position peaked at $98.9K in Q2 2024. 41 funds tracked by Wall St. Rank hold BCAB as of Q1 2025.

  • Point72 Asia (Singapore) reported no remaining BioAtla position as of Q1 2025 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 477 BioAtla shares in Q1 2025, an estimated $14.1K.
  • Point72 Asia (Singapore) first reported a position in BioAtla in Q2 2024 and held it in 3 quarters.
  • Point72 Asia (Singapore)'s BioAtla position peaked at $98.9K in Q2 2024.
  • 41 funds tracked by Wall St. Rank held BioAtla as of Q1 2025.

Based on Point72 Asia (Singapore)'s 13F filing for Q1 2025, filed 15 May 2025.